Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation

Abstract

Tel-Abl and Tel-Jak2 are fusion proteins associated with human haematologic neoplasms. They possess constitutive tyrosine kinase activity and activate common downstream signalling pathways like Stat-5, PI3-K/Akt, Ras/MapK and NF-κB. In this study, we showed the specific requirement of Src family members for the Tel-Abl-mediated cell growth, activation of Stat5, PI3-K/Akt and Ras/MapK while dispensable for Tel-Jak2. Hck was found strongly phosphorylated in Tel-Abl-expressing Ba/F3 cells and sensitive to imatinib mesylate treatment, providing evidence that Hck is a target of Tel-Abl tyrosine kinase activity. Overexpression of a kinase dead form of Hck inhibits the proliferation of Ba/F3 cells expressing Tel-Abl as the phosphorylation of Akt and Erk1/2. These results argue for an important role of Hck in Tel-Abl oncogenic signalling.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Blake RA, Broome MA, Liu X, Wu J, M, Sun L et al. (2000). SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 20: 9018–9027.

    Article  CAS  Google Scholar 

  • Briggs SD, Bryant SS, Jove R, Sanderson SD, Smithgall TE . (1995). The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck. J Biol Chem 270: 14718–14724.

    Article  CAS  Google Scholar 

  • Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel MT et al. (2000). TEL-JAK2 transgenic mice develop T-cell leukaemia. Blood 95: 3891–3899.

    CAS  PubMed  Google Scholar 

  • Cazzaniga G, Tosi S, Aloisi A, Giudici G, Daniotti M, Pioltelli P et al. (1999). The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts. Blood 94: 4370–4373.

    CAS  PubMed  Google Scholar 

  • Chin H, Arai A, Wakao H, Kamiyama R, Miyasaka N, Miura O . (1998). Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood 91: 3734–3745.

    CAS  PubMed  Google Scholar 

  • Dai Y, Rahmani M, Corey SJ, Dent P, Grant S . (2004). A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. J Biol Chem 279: 34227–34239.

    Article  CAS  Google Scholar 

  • Danhauser-Riedl S, Warmuth M, Druker BJ, Emmerich B, Hallek M . (1996). Activation of Src kinases p53/ 56lyn and p59hck by p210bcr-abl in myeloid cells. Cancer Res 56: 3589–3596.

    CAS  PubMed  Google Scholar 

  • Donato NJ, Wu JY, Stapley J, Gallick G, Lin H, Arlinghaus R et al. (2003). BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood 101: 690–698.

    Article  CAS  Google Scholar 

  • Dos Santos NR, Ghysdael J . (2005). A transgenic mouse model for TEL-JAK2-induced B-cell lymphoma/leukaemia. Leukemia 20: 182–185.

    Article  Google Scholar 

  • Ernst TJ, Slattery KE, Griffin JD . (1994). p210Bcr/Abl and p160v-Abl induce an increase in the tyrosine phosphorylation of p93c-Fes. J Biol Chem 269: 5764–5769.

    CAS  PubMed  Google Scholar 

  • Golub TR, Barker GF, Lovett M, Gilliland DG . (1994). Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77: 307–316.

    Article  CAS  Google Scholar 

  • Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK et al. (1996). Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16: 4107–4116.

    Article  CAS  Google Scholar 

  • Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ et al. (1996). Discovery of a novel, potent, and Src family selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependentT cell activation. J Biol Chem 271: 695–701.

    Article  CAS  Google Scholar 

  • Ho JM, Nguyen MH, Dierov JK, Badger KM, Beattie BK, Tartaro P et al. (2002). TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways. Blood 100: 1438–1448.

    CAS  PubMed  Google Scholar 

  • Hu Y, Liu Y, Pelletier S, Buchdunger E, Warmuth M, Fabbro D et al. (2004). Requirement of Src kinases Lyn, Hck and Fgr for Bcr-Abl1-induced B-lymphoblastic leukaemia but not chronic myeloid leukaemia. Nat Genet 36: 453–461.

    Article  CAS  Google Scholar 

  • Keung YK, Beaty M, Steward W, Jackle B, Pettnati M . (2002). Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: case report and review of the literature. Cancer Genet Cytogenet 138: 139–142.

    Article  CAS  Google Scholar 

  • Klejman A, Schreiner SJ, Nieborowska-Skorska M, Slupianek A, Wilson M, Smithgall TE et al. (2002). The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. EMBO J 21: 5766–5774.

    Article  CAS  Google Scholar 

  • Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PH . (1998). A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18: 184–187.

    Article  CAS  Google Scholar 

  • Kuno Y, Abe A, Emi N, Iida M, Yokozawa T, Towatari M et al. (2001). Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12). Blood 97: 1050–1055.

    Article  CAS  Google Scholar 

  • Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffe M, Mayeux P et al. (2000). Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood 95: 2076–2083.

    CAS  PubMed  Google Scholar 

  • Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M et al. (1997). A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278: 1309–1312.

    Article  CAS  Google Scholar 

  • Lionberger JM, Wilson MB, Smithgall TE . (2000). Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl Is uppressed by kinase-defective Hck. J Biol Chem 275: 18581–18585.

    Article  CAS  Google Scholar 

  • Mao W, Irby R, Coppola D, Fu L, Wloch M, Turner J et al. (1997). Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential. Oncogene 15: 3083–3090.

    Article  CAS  Google Scholar 

  • Malinge S, Monni R, Bernard O, Penard-Lacronique V . (2006). Activation of the NF-κB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of anti-apoptotic IAP proteins and involves IKKα. Oncogene 25: 3589–3597.

    Article  CAS  Google Scholar 

  • Million RP, Aster J, Gilliland DG, Van Etten RA . (2002). The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Blood 99: 4568–4577.

    Article  CAS  Google Scholar 

  • Million RP, Harakawa N, Roumiantsev S, Varticovski L, Van Etten RA . (2004). A Direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase. Mol Cell Biol 24: 4685–4695.

    Article  CAS  Google Scholar 

  • Omura T, Sakai H, Murakami H . (2002). Acceleration of granulocyte colony-stimulating factor-induced neutrophilic nuclear lobulation by overexpression of Lyn tyrosine kinase. Eur J Biochem 269: 381–389.

    Article  CAS  Google Scholar 

  • Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE . (1992). Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res 52: 4773–4778.

    CAS  PubMed  Google Scholar 

  • Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM . (1995). The novel activation of ABL by fusion to an ets-related gene. TEL Cancer Res 55: 34–38.

    CAS  PubMed  Google Scholar 

  • Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P et al. (1997). Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9; 12) in a lymphoid and t(9; 15; 12) in a myeloid leukemia. Blood 90: 2535–2540.

    CAS  PubMed  Google Scholar 

  • Rosa Santos SC, Dumon S, Mayeux P, Gisselbrecht S, Gouilleux F . (2000). Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene 19: 1164–1172.

    Article  CAS  Google Scholar 

  • Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V, Israel MA . (1986). Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem 261: 13754–13759.

    CAS  PubMed  Google Scholar 

  • Santos SC, Monni R, Bouchaert I, Bernard O, Gisselbrecht S, Gouilleux F et al. (2001). Involvement of the NF-KB pathway in the transforming properties of the TEL-Jak2 leukemogenic fusion protein. FEBS Lett 497: 148–152.

    Article  CAS  Google Scholar 

  • Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J . (2000). Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 289: 1938–1942.

    Article  CAS  Google Scholar 

  • Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS et al. (1998). Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. EMBO J 17: 5321–5333.

    Article  CAS  Google Scholar 

  • Spiekermann K, Pau M, Schwab R, Schmieja K, Franzrahe S, Hiddemann W . (2002). Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells. Exp Hematol 30: 262–271.

    Article  CAS  Google Scholar 

  • Stanglmaier M, Warmuth M, Kleinlein I, Reis S, Hallek M . (2003). The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains. Leukemia 17: 283–289.

    Article  CAS  Google Scholar 

  • Talamonti MS, Roh MS, Curley SA, Gallick GE . (1993). Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest 91: 53–60.

    Article  CAS  Google Scholar 

  • Tatton L, Morley GM, Chopra R, Khwaja A . (2003). The Src-selective kinase knhibitor PP1 also Inhibits Kit and Bcr-Abl tyrosine kinases. J Biol Chem 278: 4847–4853.

    Article  CAS  Google Scholar 

  • Tatosyan AG, Mizenina OA . (2000). Kinases of the Src family: structure and functions. Biochemistry (Moscow) 65: 49–58.

    CAS  Google Scholar 

  • Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK et al. (2001). Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn. Cancer Res 61: 2453–2458.

    CAS  PubMed  Google Scholar 

  • Van Limbergen H, Beverloo HB, van Drunen E, Janssens A, Hahlen K, Poppe B et al. (2001). Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia. Genes Chromosomes Cancer 30: 274–282.

    Article  CAS  Google Scholar 

  • Voss J, Posern G, Hannemann JR, Wiedemann LM, Turhan AG, Poirel H et al. (2000). The Leukaemic Bcr-Abl et Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways. Oncogene 19: 1684–1690.

    Article  CAS  Google Scholar 

  • Warmuth M, Bergmann M, Priess A, Hauslmann K, Emmerich B, Hallek M . (1997). The Src Family Kinase Hck Interacts with Bcr-Abl by a Kinase-independent Mechanism and Phosphorylates the Grb2-binding Site of Bcr. J Biol Chem 272: 33260–33270.

    Article  CAS  Google Scholar 

  • Warmuth M, Simon N, Mitina O, Mathes R, Fabbro D, Manley PW et al. (2003). Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases. Blood 101: 664–672.

    Article  CAS  Google Scholar 

  • Wilson MB, Schreiner SJ, Choi HJ, Kamens J, Smithgall TE . (2002). Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis. Oncogene 21: 8075–8088.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from ARC (Association de la Recherche contre le Cancer), Ligue contre le Cancer (Comité du Nord-Pas de Calais), Conseil Régional de Picardie, Fondation de France, Cent pour Sang la Vie and National Institutes of Health (grant CA101828 to TES). CP is supported by ARERS-Verre Espoir and Fondation pour la Recherche Médicale and R N by the ‘Ministere de la Recherche’.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F Gouilleux.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pecquet, C., Nyga, R., Penard-Lacronique, V. et al. The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation. Oncogene 26, 1577–1585 (2007). https://doi.org/10.1038/sj.onc.1209949

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209949

Keywords

This article is cited by

Search

Quick links